The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Makolina N.P.

FGBU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia RF, Moskva

Platonova N.M.

Endocrinology Research Centre, Moscow, Russia

Melnichenko G.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia;
Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia

The follow-up and treatment of differentiated thyroid cancer and postoperative hypoparathyroidism during gestation

Authors:

Makolina N.P., Platonova N.M., Melnichenko G.A.

More about the authors

Read: 2208 times


To cite this article:

Makolina NP, Platonova NM, Melnichenko GA. The follow-up and treatment of differentiated thyroid cancer and postoperative hypoparathyroidism during gestation. Russian Journal of Human Reproduction. 2013;(6):75‑81. (In Russ.)

Recommended articles:
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Modern aspe­cts of gestational diabetes mellitus: defi­nition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

References:

  1. Rumyantsev P.O., Il'in A.A., Rumyantseva U.V., Saenko V.A. Rak shchitovidnoi zhelezy. M: GEOTAR-Media 2009; 29-30.
  2. Statistika zlokachestvennykh novoobrazovanii v Rossii i stranakh SNG v 2004 g. Vestn RONTs im. N.N. Blokhina RAMN 2006; 17: 3: 47.
  3. Natsional'nye klinicheskie rekomendatsii po diagnostike i lecheniyu differentsirovannogo raka shchitovidnoi zhelezy. Endokrin khir 2008; 1: 2: 3-5.
  4. Dedov I.I., Mel'nichenko G.A., Fadeev V.V. i dr. Klinicheskie rekomendatsii Rossiiskoi Assotsiatsii Endokrinologov po diagnostike i lecheniyu uzlovogo zoba. Vserossiiskii tireoidologicheskii kongress, 3-i: Materialy. M 2004; 5-12.
  5. Lesnikova S.V., Fadeev V.V., Mel'nichenko G.A. Osobennosti nablyudeniya i osnovnye printsipy lecheniya gipoparatireoza vo vremya beremennosti i v poslerodovom periode. Doktor Ru 2011; 9: 68: 20-26.
  6. Stagnaro-Green A., Abalovich M., Alexander E. et al. Guidelines of the American thyroid association?for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 21: 1081-1125.
  7. Schlumberger M.J. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306.
  8. Mazzaferri E.L. Approach to the pregnant patient with thyroid cancer. J Clin Endocrinol Metabol 2011; 96: 2: 265-272.
  9. Gharib H., Papini E., Valcavi R. et al. AACE/AME Task Force on Thyroid Nodules American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrinol Pract 2006; 12: 63-102.
  10. Cooper D.S., Doherty G.M., Haugen B.R. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
  11. Pacini F., Schlumberger M., Dralle H. et al. European Thyroid Cancer Taskforce European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803.
  12. Yasmeen S., Cress R., Romano P.S. et al. Thyroid cancer in pregnancy. Int J Gynaecol Obstet 2005; 91: 1: 15-20.
  13. Lansdown A., Rees D.A. Endocrine oncology in pregnancy. J Clin Endocrinol Metabol 2011; 25: 6: 911-926.
  14. Moosa M., Mazzaferri E.L. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metabol 1997; 82: 9: 2862-2866.
  15. Vannucchi G., Perrino M., Rossi S. et al. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 2010; 162: 145-151.
  16. Hall P., Holm L.E., Lundell G. et al. Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients. Acta Oncol 1992; 31: 403-407.
  17. Sawka A.M., Lakra D.C., Lea J. et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxford) 2008; 69: 3: 479-490.
  18. Sioka C., Fotopoulos A. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril 2011; 95: 5: 1552-1559.
  19. Schlumberger M., De Vathaire F., Ceccarelli C. et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996; 37: 4: 606-612.
  20. Chow S.M., Yau S., Lee S.H. et al. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactiveiodine treatment. Int J Radiat Oncol Biol Phys 2004; 59: 4: 992-1000.
  21. Chen A.Y., Levy L., Goepfert H. et al. The development of breast carcinoma in women with thyroid carcinoma. Cancer 2001; 92: 225-231.
  22. Brown A.P., Chen J., Hitchcock Y.J. et al. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metabol 2008; 93: 2: 504-515.
  23. Edhemovic I., Volk N., Auersperg M. Second primary cancers following thyroid cancer in Slovenia. A population-based cohort study. Eur J Cancer 1998; 34: 1813-1814.
  24. Rubino C., de Vathaire F., Dottorini M.E. et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003; 89: 9: 1638-1644.
  25. Vini L., Hyer S., Al-Saadi A. et al. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002; 78: 916: 92-93.
  26. Casara D., Rubello D., Saladini G. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations. Eur J Nucl Med 1993; 20: 3: 192-194.
  27. Pomorski L., Bartos M., Narebski J. Pregnancy following operative and complementary treatment of thyroid cancer. Zentralbl Gynakol 2000; 122: 7: 383-386.
  28. Leboeuf R., Emerick L.E., Martorella A.J. et al. Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors. Thyroid 2007; 17: 6: 543-547.
  29. Hirsch D., Levy S., Tsvetov G. et al. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid 2010; 20: 10: 1179-1185.
  30. Rosario P.W., Barroso A.L., Purisch S. The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of the disease. Thyroid 2007; 17: 1175-1176.
  31. Kaplan M.M. Assessment of thyroid function during pregnancy. Thyroid 1992; 2: 57-61.
  32. Neto L.V., De Almeida C.A., Da Costa S.M. et al. Prospective evaluation of pregnant women with hypothyroidism: implications for treatment. Gynecol Endocrinol 2007; 23: 138-141.
  33. Mandel S.J., Larsen P.R., Seely E.W. et al. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990; 323: 91-96.
  34. Alexander E.K., Marqusee E., Lawrence J. et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351: 241-249.
  35. Loh J.A., Wartofsky L., Jonklaas J. The Magnitude of Increased Levothyroxine Requirements in Hypothyroid Pregnant Women Depends upon the Etiology of the Hypothyroidism. Thyroid 2009; 19: 3: 269-275.
  36. Casey B.M., Dashe J.S., Wells C.E. et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107: 2: 337-341.
  37. Yassa L., Marqusee E., Fawcett R. et al. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metabol 2010; 95: 7: 3234-3241.
  38. Abalovich M., Amino N., Barbour L.A. et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metabol 2007; 92: Suppl: 1-47.
  39. Hundahl S.A., Cady B., Cunningham M.P., Mazzaferri E. et al. Enitial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German thyroid cancer study group. An American college of surgeons commission on cancer patient care evaluation study. Cancer 2000; 89: 1: 202-217.
  40. Serpell J.W., Phan D. Safety of total thyroidectomy. ANZ J Surg 2007; 77: 1-2: 15-19.
  41. Dionigi G., Bacuzzi A., Bertocchi V. et al. Prospectives and surgical usefulness of perioperative parathyroid hormone assay in thyroid surgery. Exp Rev Med Dev 2008; 5: 6: 699-704.
  42. O'Leary J.A., Klainer L.M., Neuwirth R.S. The management of hypoparathyroidism in pregnancy. Am J Obstet Gynecol 1966; 94: 8: 1103-1107.
  43. Krysiak R., Kobielusz-Gembala I., Okopien B. Hypoparathyroidism in pregnancy. Gynecol Endocrinol 2011; 77: 8: 529-532.
  44. Salle B.L., Berthezene F., Glorieux F.H. et al. Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metabol 1981; 52: 4: 810-813.
  45. Callies F. et al. Management of hypoparathyroidism during pregnancy: report of twelve cases. Eur J Endocrinol 1998; 139: 3: 284-289.
  46. Akhtar N. Pregnancy with hypoparathyroidism - a case report. BSMMU J 2010; 3: 2: 107-109.
  47. Sweeney L.L., Malabanan A.O., Rosen H. Decreased calcitriol requirement during pregnancy and lactation with a window of increased requirement immediately postpartum. Endocrinol Pract 2010; 16: 3: 459-462.
  48. Cross N.A. et al. Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 1995; 61: 3: 514-523.
  49. Vanderpump M.P., Alexander L., Scarpello J.H. et al. An audit of the management of thyroid cancer in a district general hospital. Clin Endocrinol (Oxford) 1998; 48: 4: 419-424.
  50. Kumar H., Daykin J., Holder R. et al. An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings. Clin Endocrinol (Oxford) 2001; 54: 6: 719-723.
  51. Improving Outcomes in Head and Neck Cancer. The Manual, National Institute of Clinical Excellence. 2004. http://www. nice.org.uk.
  52. Tazebay U.H., Wapnir I.L., Levy O. et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000; 6: 8: 871-878.
  53. Hammami M.M., Bakheet S. Radioiodine breast uptake in nonbreastfeeding women: clinical and scintigraphic characteristics. J Nucl Med 1996; 37: 1: 26-31.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.